Guangzhou Science and Technology Program key projects Report issue

Government

Organization Overview

First Clinical Trial
2012
NCT02022228
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

human choriogonadotropin alfa (hCG) (1 trial)

triptorelin (Trelstar) (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2